Bipolar treatment leads to rapid antidepressant effects
A treatment for patients with bipolar I or bipolar II depression has demonstrated durable antidepressant effects, results show. Elunetirom, developed by Autobahn Therapeutics, is a novel, oral, once daily, brain-penetrant CNS thyroid hormone receptor agonist. In the Phase II AMPLIFY-BD trial, elunetirom was evaluated as an adjunctive… Read More